5321-47-1

Basic information

• Product Name: 1-(2-METHYLBENZYL)PIPERAZINE
• Synonyms: TIMTEC-BB SBB007006;CHEMBRDG-BB 4004071;ART-CHEM-BB B004006;1-(2-METHYLBENZYL)PIPERAZINE;AKOS B004006;1-(2-methylbenzyl)piperazine(SALTDATA: 2HCl 0.14H2O)
• CAS NO: 5321-47-1
• Molecular Formula: C₁₂H₁₈N₂
• Molecular Weight: 190.28
• EINECS: 226-183-9
• Product Categories: API intermediates;Building Blocks;Heterocyclic Building Blocks;Piperazines;Building Blocks;C12;Chemical Synthesis;Heterocyclic Building Blocks
• Mol File: 5321-47-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 77-80 °C0.1 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: /Liquid
• Density: 0.998 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00168mmHg at 25°C
• Refractive Index: n20/D 1.5430(lit.)
• PKA: 9.14±0.10(Predicted)
• CAS DataBase Reference: 1-(2-METHYLBENZYL)PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-METHYLBENZYL)PIPERAZINE(5321-47-1)
• EPA Substance Registry System: 1-(2-METHYLBENZYL)PIPERAZINE(5321-47-1)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 22-36/37/38
• Safety Statements: 26-36/37/39
• WGK Germany: 2
• Hazardous Substances Data: 5321-47-1(Hazardous Substances Data)

Usage

General Description

1-(2-Methylbenzyl)piperazine is a chemical compound classified as a piperazine derivative. It is an organic compound with the molecular formula C12H18N2. This chemical is commonly used in the synthesis of pharmaceuticals and research purposes. It possesses a piperazine backbone with a 2-methylbenzyl group attached to one of the nitrogen atoms. 1-(2-METHYLBENZYL)PIPERAZINE has potential pharmacological and therapeutic properties, and its structure makes it an interesting molecule for medicinal chemistry studies. It is important to handle and use 1-(2-Methylbenzyl)piperazine with caution, following safety guidelines and proper laboratory protocols.

InChI:InChI=1/C12H18N2/c1-11-4-2-3-5-12(11)10-14-8-6-13-7-9-14/h2-5,13H,6-10H2,1H3

Upstream product

• 110-85-0 piperazine 
• 89-92-9 2-methylbenzyl bromide 
• 7542-23-6 piperazine hydrochloride 
• 552-45-4 1-chloromethyl-2-methylbenzene 

Downstream Products

• 4440-01-1 lithium phenylacetylide 
• 1289155-06-1 (S)-2-((1-(benzylsulfonyl)pyrrolidin-3-yl)amino)-1-(4-(2-methylbenzyl)piperazin-1-yl)ethanone 
• 923121-77-1 2-chloro-1-(4-(2-methylbenzyl)piperazin-1-yl)ethanone 
• 116028-12-7 1-[2-(2-methyl-benzhydryloxy)-ethyl]-4-(2-methyl-benzyl)-piperazine 
• 1589517-80-5 5-(1,2-dithiolan-3-yl)-1-(4-(2-methylbenzyl)piperazin-1-yl)pentan-1-one 
• 1428245-47-9 C₁₉H₂₃ClN₂O₃ 

Relevant articles and documents

Design, synthesis and SAR of antitubercular benzylpiperazine ureas

Abstract: N-furfuryl piperazine ureas disclosed by scientists at GSK Tres Cantos were chosen as antimycobacterial hits from a phenotypic whole-cell screen. Bioisosteric replacement of the furan ring in the GSK Tres Cantos molecules with a phenyl ring led to molecule (I) with an MIC of 1?μM against Mtb H37Rv, low cellular toxicity (HepG2 IC50 ~ 80?μM), good DMPK properties and specificity for Mtb. With the aim of delineating the SAR associated with (I), fifty-five analogs were synthesized and screened against Mtb. The SAR suggests that the piperazine ring, benzyl urea and piperonyl moieties are essential signatures of this series. Active compounds in this series are metabolically stable, have low cellular toxicity and are valuable leads for optimization. Molecular docking suggests these molecules occupy the Q0 site of QcrB like Q203. Graphic Abstract: Bioisosteric replacement of N-furfuryl piperazine-1-carboxamides yielded molecule (I) a novel lead with satisfactory PD, metabolism, and toxicity profiles.[Figure not available: see fulltext.]

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model

The nonselective Ca2+-permeable transient receptor potential (TRP) channels play important roles in diverse cellular processes, including actin remodeling and cell migration. TRP channel subfamily C, member 5 (TRPC5) helps regulate a tight balance of cytoskeletal dynamics in podocytes and is suggested to be involved in the pathogenesis of proteinuric kidney diseases, such as focal segmental glomerulosclerosis (FSGS). As such, protection of podocytes by inhibition of TRPC5 mediated Ca2+ signaling may provide a novel therapeutic approach for the treatment of proteinuric kidney diseases. Herein, we describe the identification of a novel TRPC5 inhibitor, GFB-8438, by systematic optimization of a high-throughput screening hit, pyridazinone 1. GFB-8438 protects mouse podocytes from injury induced by protamine sulfate (PS) in vitro. It is also efficacious in a hypertensive deoxycorticosterone acetate (DOCA)-salt rat model of FSGS, significantly reducing both total protein and albumin concentrations in urine.

INHIBITORS OF STEAROYL-COA DESATURASE

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.